Blog
12-17-2024In a message to the substance use treatment and public health communities, CDC and SAMHSA leaders highlight the need for and opportunities to increase the provi…
IDU
CDC and SAMHSA Leaders Encourage HIV and Viral Hepatitis Testing in Substance Use Disorder Treatment - Blog
HRSA Funding Opportunity for Rural Communities Opioid Response Program Implementation 11-03-2021The Health Resources and Services Administration s (HRSA) Federal Office of Rural Health Policy (FORHP) is acc... - Blog
NIDA Funding Research on PrEP for HIV Prevention Among Substance Using Populations 08-03-2021 - Blog
HRSA Publishes on Ryan White HIV/AIDS Program’s Response to the Opioid Epidemic 10-02-2020 - Blog
Webinar: Syringe Service Programs – A Critical Public Health Intervention 07-18-2019 - Blog
Reminder: July 15 Deadline for Abstracts on Injection Drug Use 07-05-2019 - Blog
Syringe Service Programs Are Safe, Effective, and Cost-Saving 06-26-2019 - Blog
CDC Releases Materials on Syringe Services Programs 05-24-2019 - Blog
2019 Rx Drug Abuse & Heroin Summit 04-19-2019 - Blog
Opioid Epidemic Is Increasing Rates of Some Infectious Diseases 04-12-2019Cross-posted from NIAID NewsroomThe United States faces a converging public health crisis as the nation’s opioid epidemic fuels growing rates of certain i… - Blog
SAMHSA Funding Opportunity: Increasing Engagement in Substance Use Treatment for Minorities Living with or At-risk for HIV 03-06-2019 - Blog
SAMHSA Urges Focus on Synergistic Epidemics of Substance Use Disorder, HIV, and Viral Hepatitis 02-13-2019 - Blog
Novel Intervention Halves Rate of Death Among People Living with HIV Who Inject Drugs 09-21-2018 - Blog
Dr. Redonna Chandler Selected to Lead AIDS Research Program at NIDA 02-21-2018 - Blog
SAMHSA Funding Opportunity to Integrate Mental Health & Substance Abuse Disorder Treatment with HIV Primary Care and Prevention 01-17-2018The Substance Abuse and Mental Health Services Administration s (SAMHSA) Center for Mental Health Services (CMHS)... - Blog
FDA Requests Removal of Opana ER for Risks Related to Abuse 06-29-2017 - Blog
FDA Requests Removal of Opana ER for Risks Related to Abuse 06-29-2017Crossposted from FDA Newsroom Note: Earlier this month, the FDA requested that a drug company remove an opioid pain medication, Opana ER, from the market becau.… - Blog
National Drug Abuse Summit to Address Infectious Disease Consequences of Opioid Crisis 03-15-2017 - Blog
Join CDC's Vital Signs Town Hall Teleconference! 12-12-2016 - Blog
Syringe Services Programs: Effective for HIV Prevention 12-05-2016